paeonol has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, M; He, H; Huang, H; Liu, Y; Shi, X; Sun, Y; Wu, H; Xie, X | 1 |
| Dai, M; Gu, CG; Liu, QY; Zhang, HY | 1 |
2 other study(ies) available for paeonol and Hyperlipidemias
| Article | Year |
|---|---|
Paeonol inhibits NLRP3 mediated inflammation in rat endothelial cells by elevating hyperlipidemic rats plasma exosomal miRNA-223.
Topics: Acetophenones; Animals; Cell Survival; Cytokines; Diet, High-Fat; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Exosomes; Hyperlipidemias; Inflammasomes; Inflammation; Inflammation Mediators; Male; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley | 2020 |
[Inhibitory effect of paeonol on lipid peroxidational reaction and oxidational decorate of low density lipoprotein].
Topics: Acetophenones; Animals; Aorta; Humans; Hyperlipidemias; Lipid Peroxidation; Lipoproteins, LDL; Liver; Male; Oxidation-Reduction; Paeonia; Plants, Medicinal; Random Allocation; Rats; Rats, Wistar | 2000 |